Dr. M. Wajid Sadiq
Resident Medicine
CMH/SKBZ Rawlakot
 A 44 year old man presented in ER with the 3
hours history of SOB, restlessness,
palpitations, nausea and substernal chest
pain radiating to jaws and left arm, increasing
in intensity with minimal exertion. His BP
140/90mmHg, PaO2 91%, plasma glucose
110mg/dl, pulse 65/min, R/R 22/min at the
time of presentation. His past medical history
is insignificant for DM or other systemic
illness. His ECG was recorded at the time of
presentation is given below
based on history, physical examination and
ECG what is next step of management?
 Contents
Definition
Types of Infarcts
Etiology
Pathiophysiology
Clinical manifestations
Diagnosis
Management
 MI is defined as a diseased condition which is
caused by reduced blood flow in a coronary
artery due to atherosclerosis and occlusion of
an artery by an embolus or thrombus.
 MI or heart attack is the irreversible damage
of myocardial tissue caused by prolonged
ischemia and hypoxia.
 According to anatomic region of left ventricle
involved:
Anterior, Posterior, Lateral, Septal,
circumferential and combinations
anterioseptal, anteriolateral, posteriolateral.
According to thickness of ventricles
Transmural, Laminar(subendocardial)
 Tobacco smoking
 Hypertension
 DM and other systemic diseases
 Drug abuse
 Obesity
 Stress
 Alcohol
 Age and gender
 Most patients who sustain an MI have
coronary atherosclerosis.
 The thrombus formation occurs most often at
the site of an atherosclerotic lesion, thus
obstructing blood flow to the myocardial
tissues.
 Plaque rupture is believed to be the
triggering mechanism for the development of
the thrombus in most patients with an MI.
 When the plaques rupture, a thrombus is
formed at the site that can occlude blood
flow, thus resulting in an MI.
 Irreversible damage to the myocardium can begin
as early as 20 to 40 minutes after interruption of
blood flow.
 The dynamic process of infarction may not be
completed, however, for several hours.
 Necrosis of tissue appears to occur in a
sequential fashion.
 Reimer and associates demonstrated that cellular
death occurs first in the subendocardial layer and
spreads like a “wavefront” throughout the
thickness of the wall of the heart.
 Using dogs, they showed that the shorter the
time between coronary occlusion and coronary
reperfusion, the greater the amount of
myocardial tissue that could be salvaged.
 a substantial amount of myocardial tissue can
be salvaged if flow is restored within 6 hours
after the onset of coronary occlusion.
 The cellular changes associated with an MI
can be followed by:
1. the development of infarct extension (new
myocardial necrosis),
2. infarct expansion (a disproportionate
thinning and dilation of the infarct zone), or
3. Ventricular remodeling (a disproportionate
thinning and dilation of the ventricle).
 Chest pain/chest discomfort
 Dyspnea
 Fatigue
 Others (sweating, weakness, nausea,
vomiting, palpitations)
 Anxiety, hypotension, hypertension,
arrhythmias.
 Cardiac enzymes
 Lactate dehydrogenases
 Cardiac specific troponins
 ECG (st elevation, t wave inversion, wide deep
Q waves can also appear)
Laboratory Tests
 Creatine Kinase
 CK-MB appears in the serum in 6 to 12 hours,
peaks between 12 and 28 hours, and returns
to normal levels in about 72 to 96 hours.
 Serial samplings are performed every 4 to 6
hours for the first 24 to 48 hours after the
onset of symptoms
 Creatine Kinase Isoforms: CK-MB1 is the
isoform found in the plasma, and CK-MB2 is
found in the tissues. In the patient with an MI,
the CK-MB2 level rises, resulting in a CK-MB2
to CK-MB1 ratio greater than one
 Troponin. (troponin T and troponin I):
 Troponin I levels rise in about 3 hours, peak
at 14 to 18 hours, and remain elevated for 5
to 7 days.
 Troponin T levels rise in 3 to 5 hours and
remain elevated for 10 to 14 days
 Myoglobin: Myoglobin is an oxygen-binding
protein found in skeletal and cardiac muscle.
Myoglobin’s release from ischemic muscle
occurs earlier than the release of CK.
 The myoglobin level can elevate within 1 to 2
hours of acute MI and peaks within 3 to 15
hours.
 Because myoglobin is also present in skeletal
muscle, an elevated myoglobin level is not
specific for the diagnosis of MI. onsequently,
its diagnostic value in detecting an MI is
limited
 Non pharmacological: counselling and
education of patients, life style modification,
smoking cessation, avoid alcohol, diet and
nutrition, salt restriction
 Pharmacological:
◦ Thrombolytics
◦ Anticoagulants
◦ Antiplatelets
◦ Antihypertensive agents
◦ Lipid lowering drugs
◦ Analgesics, antiulcers, and sometimes
antidepressants
 Give O2 to maintain spo2 92-98% and attach
cardiac monitor
 Obtain iv access and send blood for baseline
investigations.
 Provide small increments of IV opioid
analgesia
 Ensure the patient has had 300mg aspirin
and 300 mg clopidogrel PO.
 Contact cardiologist for PCI
 If PCI is not available consider thrombolysis
and monitor carefully.
 If pain continues, give GTN @ 0.6mg/hr and
can increase if necessary
 Consider atenolol(5mg iv slowly over 5 min
and repeat after 15 mins) or metoprolol
unless contraindicated (uncontrolled heart
failure, hypotension, bradyarrythmias, COPD,
asthma)
 thrombolysis
 ST elevation of >1mm in 2 limb leads or
 ST elevation of > or equal to 2mm in 2 or
more contiguous chest leads or
 LBBB in the presence of a typical history of
acute MI (LBBB has not to be new.
 PCI is treatment of choice for STEMI, if PCI
cant be performed within 90 mins of
diagnosis then thrombolysis is an alternative.
Patient presenting > 12 hrs after symptoms
onset will not benefit from thrombolysis.
 Head injury, recent stroke, previous
neurosurgery or cerebral tumor.
 Recent GI bleeding, menstruation or
coagulopathy/warfarin.
 Severe hypertension(systolic >200mmHg,
diastolic>120mmHg), aortic dissection or
pericarditis.
 Puncture of non-compressible vessels e.g
subclavian, traumatic CPR, decrease GCS
post arrest.
 Major surgery with in recent weeks.
 Pregnancy
 Arrythmias
 Cardiogenic shock
 CCF
 Thromboembolism
 Rupture
 Cardiac aneurism
 Pericarditis
Vascular Complications
 Recurrent ischemia
 Recurrent infarction
Mechanical Complications
 Left ventricular free wall
rupture
 Ventricular septal rupture
 Papillary muscle rupture
with acute mitral
regurgitation
Myocardial Complications
 Diastolic dysfunction
 Systolic dysfunction
 Congestive heart failure
 Hypotension/cardiogenic
shock
 Right ventricular
infarction
 Ventricular cavity dilation
 Aneurysm formation
(true, false)
Pericardial Complications
 Pericarditis
 Dressler’s syndrome
 Pericardial effusion
Thromboembolic
Complications
 Mural thrombosis
 Systemic
thromboembolism
 Deep venous thrombosis
 Pulmonary embolism
Electrical Complications
 Ventricular tachycardia
 Ventricular fibrillation
 Supraventricular
tachydysrhythmias
 Bradydysrhythmias
 Atrioventricular block
(first, second, or third
degree)

MI.ppt

  • 1.
    Dr. M. WajidSadiq Resident Medicine CMH/SKBZ Rawlakot
  • 2.
     A 44year old man presented in ER with the 3 hours history of SOB, restlessness, palpitations, nausea and substernal chest pain radiating to jaws and left arm, increasing in intensity with minimal exertion. His BP 140/90mmHg, PaO2 91%, plasma glucose 110mg/dl, pulse 65/min, R/R 22/min at the time of presentation. His past medical history is insignificant for DM or other systemic illness. His ECG was recorded at the time of presentation is given below
  • 5.
    based on history,physical examination and ECG what is next step of management?
  • 7.
     Contents Definition Types ofInfarcts Etiology Pathiophysiology Clinical manifestations Diagnosis Management
  • 8.
     MI isdefined as a diseased condition which is caused by reduced blood flow in a coronary artery due to atherosclerosis and occlusion of an artery by an embolus or thrombus.  MI or heart attack is the irreversible damage of myocardial tissue caused by prolonged ischemia and hypoxia.
  • 9.
     According toanatomic region of left ventricle involved: Anterior, Posterior, Lateral, Septal, circumferential and combinations anterioseptal, anteriolateral, posteriolateral. According to thickness of ventricles Transmural, Laminar(subendocardial)
  • 10.
     Tobacco smoking Hypertension  DM and other systemic diseases  Drug abuse  Obesity  Stress  Alcohol  Age and gender
  • 11.
     Most patientswho sustain an MI have coronary atherosclerosis.  The thrombus formation occurs most often at the site of an atherosclerotic lesion, thus obstructing blood flow to the myocardial tissues.  Plaque rupture is believed to be the triggering mechanism for the development of the thrombus in most patients with an MI.  When the plaques rupture, a thrombus is formed at the site that can occlude blood flow, thus resulting in an MI.
  • 12.
     Irreversible damageto the myocardium can begin as early as 20 to 40 minutes after interruption of blood flow.  The dynamic process of infarction may not be completed, however, for several hours.  Necrosis of tissue appears to occur in a sequential fashion.  Reimer and associates demonstrated that cellular death occurs first in the subendocardial layer and spreads like a “wavefront” throughout the thickness of the wall of the heart.  Using dogs, they showed that the shorter the time between coronary occlusion and coronary reperfusion, the greater the amount of myocardial tissue that could be salvaged.
  • 13.
     a substantialamount of myocardial tissue can be salvaged if flow is restored within 6 hours after the onset of coronary occlusion.  The cellular changes associated with an MI can be followed by: 1. the development of infarct extension (new myocardial necrosis), 2. infarct expansion (a disproportionate thinning and dilation of the infarct zone), or 3. Ventricular remodeling (a disproportionate thinning and dilation of the ventricle).
  • 14.
     Chest pain/chestdiscomfort  Dyspnea  Fatigue  Others (sweating, weakness, nausea, vomiting, palpitations)  Anxiety, hypotension, hypertension, arrhythmias.
  • 15.
     Cardiac enzymes Lactate dehydrogenases  Cardiac specific troponins  ECG (st elevation, t wave inversion, wide deep Q waves can also appear)
  • 16.
    Laboratory Tests  CreatineKinase  CK-MB appears in the serum in 6 to 12 hours, peaks between 12 and 28 hours, and returns to normal levels in about 72 to 96 hours.  Serial samplings are performed every 4 to 6 hours for the first 24 to 48 hours after the onset of symptoms  Creatine Kinase Isoforms: CK-MB1 is the isoform found in the plasma, and CK-MB2 is found in the tissues. In the patient with an MI, the CK-MB2 level rises, resulting in a CK-MB2 to CK-MB1 ratio greater than one
  • 17.
     Troponin. (troponinT and troponin I):  Troponin I levels rise in about 3 hours, peak at 14 to 18 hours, and remain elevated for 5 to 7 days.  Troponin T levels rise in 3 to 5 hours and remain elevated for 10 to 14 days
  • 18.
     Myoglobin: Myoglobinis an oxygen-binding protein found in skeletal and cardiac muscle. Myoglobin’s release from ischemic muscle occurs earlier than the release of CK.  The myoglobin level can elevate within 1 to 2 hours of acute MI and peaks within 3 to 15 hours.  Because myoglobin is also present in skeletal muscle, an elevated myoglobin level is not specific for the diagnosis of MI. onsequently, its diagnostic value in detecting an MI is limited
  • 20.
     Non pharmacological:counselling and education of patients, life style modification, smoking cessation, avoid alcohol, diet and nutrition, salt restriction  Pharmacological: ◦ Thrombolytics ◦ Anticoagulants ◦ Antiplatelets ◦ Antihypertensive agents ◦ Lipid lowering drugs ◦ Analgesics, antiulcers, and sometimes antidepressants
  • 21.
     Give O2to maintain spo2 92-98% and attach cardiac monitor  Obtain iv access and send blood for baseline investigations.  Provide small increments of IV opioid analgesia  Ensure the patient has had 300mg aspirin and 300 mg clopidogrel PO.  Contact cardiologist for PCI  If PCI is not available consider thrombolysis and monitor carefully.
  • 22.
     If paincontinues, give GTN @ 0.6mg/hr and can increase if necessary  Consider atenolol(5mg iv slowly over 5 min and repeat after 15 mins) or metoprolol unless contraindicated (uncontrolled heart failure, hypotension, bradyarrythmias, COPD, asthma)  thrombolysis
  • 23.
     ST elevationof >1mm in 2 limb leads or  ST elevation of > or equal to 2mm in 2 or more contiguous chest leads or  LBBB in the presence of a typical history of acute MI (LBBB has not to be new.  PCI is treatment of choice for STEMI, if PCI cant be performed within 90 mins of diagnosis then thrombolysis is an alternative. Patient presenting > 12 hrs after symptoms onset will not benefit from thrombolysis.
  • 24.
     Head injury,recent stroke, previous neurosurgery or cerebral tumor.  Recent GI bleeding, menstruation or coagulopathy/warfarin.  Severe hypertension(systolic >200mmHg, diastolic>120mmHg), aortic dissection or pericarditis.  Puncture of non-compressible vessels e.g subclavian, traumatic CPR, decrease GCS post arrest.
  • 25.
     Major surgerywith in recent weeks.  Pregnancy
  • 27.
     Arrythmias  Cardiogenicshock  CCF  Thromboembolism  Rupture  Cardiac aneurism  Pericarditis
  • 28.
    Vascular Complications  Recurrentischemia  Recurrent infarction Mechanical Complications  Left ventricular free wall rupture  Ventricular septal rupture  Papillary muscle rupture with acute mitral regurgitation Myocardial Complications  Diastolic dysfunction  Systolic dysfunction  Congestive heart failure  Hypotension/cardiogenic shock  Right ventricular infarction  Ventricular cavity dilation  Aneurysm formation (true, false)
  • 29.
    Pericardial Complications  Pericarditis Dressler’s syndrome  Pericardial effusion Thromboembolic Complications  Mural thrombosis  Systemic thromboembolism  Deep venous thrombosis  Pulmonary embolism Electrical Complications  Ventricular tachycardia  Ventricular fibrillation  Supraventricular tachydysrhythmias  Bradydysrhythmias  Atrioventricular block (first, second, or third degree)